{"output": [["Sarepta Therapeutics", "ORG", "Operate_In", "Biopharmaceutical Industry", "SECTOR"], ["Sarepta Therapeutics", "ORG", "Introduce", "EXONDYS 51", "PRODUCT"], ["EXONDYS 51", "PRODUCT", "Has", "PMO chemistry", "CONCEPT"], ["EXONDYS 51", "PRODUCT", "Has", "Exon-skipping technology", "CONCEPT"], ["EXONDYS 51", "PRODUCT", "Operate_In", "DMD treatment", "SECTOR"], ["Sarepta Therapeutics", "ORG", "Provide", "Revenue guidance", "CONCEPT"], ["EXONDYS 51", "PRODUCT", "Impact", "Sarepta Therapeutics revenue", "ECON_INDICATOR"], ["Sarepta Therapeutics", "ORG", "Plan", "Multiple milestones", "CONCEPT"], ["Sarepta Therapeutics", "ORG", "Plan", "Inflection points", "CONCEPT"], ["Sarepta Therapeutics", "ORG", "Aspire", "Global leadership in precision genetic medicine", "CONCEPT"], ["DMD", "CONCEPT", "Relate_To", "EXONDYS 51", "PRODUCT"], ["DMD", "CONCEPT", "Relate_To", "Sarepta Therapeutics", "ORG"]], "published": "2018-01-08T21:42:00.000+02:00"}